Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$54.97 USD

54.97
3,474,229

-1.97 (-3.46%)

Updated Sep 11, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (234 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Company News for Aug 8, 2019

Companies in the news are: DIS, CVS, CPRI and ODP

CVS Health (CVS) Beats on Q2 Earnings, Raises '19 Guidance

CVS Health's (CVS) second-quarter top-line growth in Pharmacy Services segment is backed by an uptick in specialty services.

U.S. Stock Index Futures Move Lower

U.S. stock index futures moved lower

Stock Futures Fall as Trade Worries Spook Wall Street

U.S. stock index futures moved lower ahead of trading on Wednesday after rising trade tensions led to concerns that a global economic slowdown was likely.

CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 11.18% and 1.31%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Sapna Bagaria headshot

Outlook for Health Insurance Industry Looks Sanguine

Consolidation, increasing senior population, technological advancements and development of supplementary healthcare businesses poise the health insurance industry for secular growth.

Christopher Vargas headshot

Buy CVS Health (CVS) Ahead of Q2 Earnings?

CVS Health (CVS) will be reporting their second quarter before the opening bell on Wednesday.

Can Pharmacy Services Drive CVS Health's (CVS) Q2 Earnings?

Akin to the previous quarters, net new business and the steady uptake of Maintenance Choice programs are likely to bolster CVS Health's (CVS) PBM business in Q2.

Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?

Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.

3 Retail Stocks Likely to Stand Tall This Earnings Season

Retailers are making prudent investments to strengthen digital ecosystem and bolster shipping and delivery capabilities. While these drive sales, they entail high costs. Margins remain one of the key areas to watch.

Cigna (CI) to Report Q2 Earnings: What's in the Offing?

Cigna's (CI) Q2 earnings should reflect increase in revenues from growth across its segments and share buyback.

CVS Health (CVS) Gains As Market Dips: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $56.26, marking a +1.3% move from the previous day.

Sweta Killa headshot

Is Deep Value ETF (DVP) a Strong ETF Right Now?

Smart Beta ETF report for DVP

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $55.47, marking a -0.84% move from the previous day.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $57.44, marking a -0.19% move from the previous day.

Sweta Jaiswal, FRM headshot

ETFs to Shine as Trump Tosses Drug Rebate Curb Plan

We study the impact of Trump's dropping of the proposed drug rebate rule on some health ETFs with exposure to pharmacy benefit managers and healthcare insurers.

The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS

The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS

Stock Market News for Jul 12, 2019

The Dow and S&P 500 closed at record highs on Thursday riding a rally among healthcare shares and Fed???s indication of an easier monetary policy.

Christopher Vargas headshot

Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play

The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.

Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Tirthankar Chakraborty headshot

Trump's Order on Kidney Care Lifts These Dialysis Stocks

Dialysis stocks move north after Trump signs an executive order designed to reform the nation's kidney treatment industry.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $54.83 in the latest trading session, marking a -0.87% move from the prior day.

CVS Health Banks on Aetna Prospects, Omnicare May Disappoint

CVS Health's (CVS) Aetna integration synergies bode well for the stock.

Here's Why CVS Health (CVS) Should Be in Your Portfolio

Investors' trust continues to be high in CVS Health (CVS), thanks to strength in its PBM business.

Kalyan Nandy headshot

Top Analyst Reports: Mastercard, Coca-Cola, Amgen & More

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Coca-Cola (KO) and Amgen (AMGN).